Area of research
Physiology · Neurology
Research interest
Research interests include Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Prion Diseases and Protein Misfolding, and Cholinesterase and Neurodegenerative Diseases.
A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies.
Liposome Nanoparticle Conjugation and Cell Penetrating Peptide Sequences (CPPs) Enhance the Cellular Delivery of the Tau Aggregation Inhibitor RI-AG03
Oxidative Stress, Cytotoxic and Inflammatory Effects of Urban Ultrafine Road-Deposited Dust from the UK and Mexico in Human Epithelial Lung (Calu-3) Cells.
Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics.
Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer's disease, from the UK.
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer's disease.
Diagnostic Biomarkers for Alzheimer's Disease Using Non-Invasive Specimens.
Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.
Nabiximols for the Treatment of Cannabis Dependence
Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.
Clinical trials of medicinal cannabis for appetite‐related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation